Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10366) 10366
Publication (696) 696
Book Review (203) 203
Book / eBook (114) 114
Book Chapter (74) 74
Magazine Article (42) 42
Newsletter (31) 31
Conference Proceeding (17) 17
Dissertation (9) 9
Newspaper Article (5) 5
Trade Publication Article (5) 5
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7274) 7274
index medicus (4990) 4990
warfarin (3725) 3725
administration, oral (3690) 3690
female (3603) 3603
male (3457) 3457
anticoagulants - administration & dosage (3072) 3072
anticoagulants (3049) 3049
aged (2930) 2930
anticoagulants - therapeutic use (2841) 2841
atrial fibrillation (2754) 2754
middle aged (2481) 2481
oral anticoagulation (2307) 2307
anticoagulants - adverse effects (2239) 2239
risk factors (2130) 2130
stroke (2013) 2013
cardiac & cardiovascular systems (1973) 1973
hematology (1809) 1809
peripheral vascular disease (1709) 1709
anticoagulation (1580) 1580
treatment outcome (1567) 1567
atrial fibrillation - drug therapy (1541) 1541
oral anticoagulants (1431) 1431
adult (1427) 1427
management (1412) 1412
aged, 80 and over (1404) 1404
dabigatran (1399) 1399
thromboembolism (1393) 1393
therapy (1372) 1372
international normalized ratio (1333) 1333
prevention (1287) 1287
hemorrhage - chemically induced (1283) 1283
atrial-fibrillation (1258) 1258
risk (1256) 1256
stroke - prevention & control (1248) 1248
rivaroxaban (1207) 1207
venous thromboembolism (1180) 1180
medicine, general & internal (1176) 1176
atrial fibrillation - complications (1168) 1168
warfarin - therapeutic use (1073) 1073
warfarin - administration & dosage (1022) 1022
thrombosis (965) 965
pharmacology & pharmacy (921) 921
retrospective studies (881) 881
stroke prevention (879) 879
warfarin - adverse effects (844) 844
antithrombotic therapy (842) 842
time factors (815) 815
care and treatment (807) 807
thromboembolism - prevention & control (794) 794
bleeding (790) 790
surgery (749) 749
apixaban (740) 740
risk assessment (739) 739
stroke - etiology (739) 739
abridged index medicus (727) 727
vitamin k - antagonists & inhibitors (699) 699
prospective studies (697) 697
oral anticoagulant-therapy (687) 687
aspirin (686) 686
patients (679) 679
medicine & public health (678) 678
drug therapy (672) 672
cardiac arrhythmia (647) 647
analysis (631) 631
cardiology (631) 631
blood coagulation - drug effects (629) 629
hemorrhage (623) 623
mortality (621) 621
safety (621) 621
follow-up studies (595) 595
deep-vein thrombosis (571) 571
molecular-weight heparin (570) 570
direct oral anticoagulants (568) 568
dosage and administration (553) 553
metaanalysis (546) 546
risk-factors (540) 540
research (509) 509
health aspects (504) 504
dose-response relationship, drug (459) 459
internal medicine (454) 454
guidelines (442) 442
complications (441) 441
incidence (437) 437
prothrombin time (436) 436
fibrillation (415) 415
drug administration schedule (413) 413
adolescent (407) 407
bleeding complications (406) 406
recurrence (401) 401
efficacy (394) 394
practice guidelines as topic (393) 393
anticoagulants - pharmacology (392) 392
oral anticoagulant (389) 389
clinical trials (386) 386
cardiovascular (385) 385
venous thromboembolism - drug therapy (384) 384
thrombin (383) 383
outcomes (381) 381
thromboembolism - etiology (380) 380
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (40) 40
Dentistry (Harry R Abbott) - Stacks (30) 30
Gerstein Science - Stacks (28) 28
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (23) 23
Dentistry (Harry R Abbott) - Withdrawn (16) 16
Dentistry (Harry R Abbott) - Circulation Desk (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Scarborough Hospital - Birchmount (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - May be requested (1) 1
Dentistry (Harry R Abbott) - Searching (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Online Resources - Online (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9470) 9470
German (460) 460
Spanish (235) 235
French (225) 225
Portuguese (52) 52
Italian (35) 35
Russian (35) 35
Japanese (33) 33
Polish (22) 22
Korean (11) 11
Hungarian (9) 9
Turkish (8) 8
Chinese (6) 6
Dutch (6) 6
Norwegian (6) 6
Czech (5) 5
Arabic (4) 4
Hebrew (4) 4
Danish (2) 2
Finnish (2) 2
Romanian (2) 2
Serbian (2) 2
Croatian (1) 1
Georgian (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Oral anticoagulation use by patients with atrial fibrillation in Germany: Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients
by Wilke, Thomas and Groth, Antje and Mueller, Sabrina and Pfannkuche, Matthias and Verheyen, Frank and Linder, Roland and Maywald, Ulf and Kohlmann, Thomas and Feng, You-Shan and Breithardt, Günter and Bauersachs, Rupert
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2012, Volume 107, Issue 6, pp. 1053 - 1065
Atrial fibrillation (AF) is the most common significant cardiac rhythm disorder. Oral anticoagulation (OAC) is recommended by guidelines in the presence of a... 
Management of disease | Antiplatelet agents | Vitamin k-dependent factors | antiplatelet agents | MANAGEMENT | STROKE PREVENTION | RISK STRATIFICATION SCHEMES | EUROPEAN-SOCIETY | ANTITHROMBOTIC TREATMENT | PREDICTION | THERAPY | management of disease | WARFARIN | PERIPHERAL VASCULAR DISEASE | CHADS | Vitamin K-dependent factors | THROMBOEMBOLISM | HEMATOLOGY | Multivariate Analysis | Stroke - prevention & control | Guideline Adherence - statistics & numerical data | Anticoagulants - administration & dosage | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Humans | Risk Factors | Logistic Models | Male | Thromboembolism - epidemiology | Anticoagulants - adverse effects | Germany - epidemiology | Practice Patterns, Physicians' - statistics & numerical data | Atrial Fibrillation - epidemiology | Thromboembolism - prevention & control | Female | Stroke - epidemiology | Aged | Hemorrhage - chemically induced | Odds Ratio | Drug Utilization - statistics & numerical data | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: An analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial
by Van Spall, Harriette G.C and Wallentin, Lars and Yusuf, Salim and Eikelboom, John W and Nieuwlaat, Robby and Yang, Sean and Kabali, Conrad and Reilly, Paul A and Ezekowitz, Michael D and Connolly, Stuart J and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala kliniska forskningscentrum (UCR)
Circulation, ISSN 0009-7322, 11/2012, Volume 126, Issue 19, pp. 2309 - 2316
Background-The outcome of atrial fibrillation patients on warfarin partially depends on maintaining adequate time in therapeutic International Normalized Ratio... 
outcomes assessment | atrial fibrillation | quality improvement | warfarin | CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULANT | MULTILEVEL ANALYSIS | ATRIAL-FIBRILLATION | STROKE | DABIGATRAN | PERIPHERAL VASCULAR DISEASE | NORMALIZED RATIO CONTROL | OUTCOMES | Stroke - prevention & control | Embolism - prevention & control | Atrial Fibrillation - drug therapy | Humans | Risk Factors | Atrial Fibrillation - complications | Proportional Hazards Models | Anticoagulants - therapeutic use | Male | Treatment Outcome | Warfarin - therapeutic use | Dose-Response Relationship, Drug | International Normalized Ratio | Regression Analysis | Algorithms | Internationality | Female | Stroke - epidemiology | Aged | Embolism - epidemiology | Usage | Warfarin | Care and treatment | Atrial fibrillation | Patient outcomes | Anticoagulants (Medicine) | Health aspects | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Probing oral anticoagulation in patients with atrial high rate episodes. Rationale and design of the Non vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH – AFNET 6) trial
by Kirchhof, Paulus and Blank, Benjamin F and Calvert, Melanie and Camm, A John and Chlouverakis, Gregory and Diener, Hans-Christoph and Goette, Andreas and Huening, Andrea and Lip, Gregory Y.H and Simantirakis, Emmanuel and Vardas, Panos
American Heart Journal, ISSN 0002-8703, 2017, Volume 190, pp. 12 - 18
Background Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation. Early detection of atrial fibrillation and subsequent... 
Cardiovascular | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | WARFARIN | CLINICAL-IMPLICATIONS | AMERICAN-COLLEGE | CARDIAC MONITOR | RISK | OPEN-LABEL | TEMPORAL RELATIONSHIP | ISCHEMIC-STROKE | Prospective Studies | Follow-Up Studies | Humans | Male | Thiazoles - administration & dosage | Atrial Fibrillation - physiopathology | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Time Factors | Female | Stroke - epidemiology | Vitamin K | Heart Rate | Stroke - prevention & control | Pyridines - administration & dosage | Survival Rate - trends | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Europe - epidemiology | Treatment Outcome | Disease-Free Survival | Stroke - etiology | Atrial Fibrillation - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Stroke patients | Atrial fibrillation | Cardiac patients | Implants, Artificial | Prosthesis | Anticoagulants | Therapy | Cardiac arrhythmia | Surgical implants | Aspirin | Stroke | Coagulation | Strokes | Patients | Bleeding | Risk factors | Vitamins | Artifacts | Fibrillation | Ischemia | Defibrillators | Pacemakers | Safety engineering | Electrocardiography | Heart diseases | Trial Design
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Anticoagulation
by Potzsch, B
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, ISSN 2193-6218, 05/2013, Volume 108, Issue 4, pp. 325 - 334
Anticoagulant drugs belong to the group of antithrombotic agents and are successfully used in the prophylaxis and treatment of thromboembolic disorders. The... 
Pulmonary embolism | Blood coagulation | MEDICINE, GENERAL & INTERNAL | DIRECT THROMBIN | DABIGATRAN | MANAGEMENT | WARFARIN | INHIBITORS | Antikoagulant | Thrombosis | Arrhythmias | Recombinant Proteins - therapeutic use | Pulmonary Embolism - prevention & control | Heparinoids - adverse effects | Factor Xa Inhibitors | Humans | Postoperative Complications - prevention & control | Heparin - therapeutic use | Secondary Prevention | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Vitamin K - antagonists & inhibitors | Pipecolic Acids - adverse effects | Thromboembolism - prevention & control | Orthopedic Procedures | Pipecolic Acids - therapeutic use | Heparinoids - therapeutic use | Venous Thrombosis - prevention & control | Thromboembolism - drug therapy | Postoperative Complications - drug therapy | Venous Thrombosis - drug therapy | Administration, Oral | Antithrombins - therapeutic use | Risk Factors | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Antithrombins - adverse effects | Hirudins - adverse effects | Blood Coagulation Tests | Pulmonary Embolism - drug therapy | Arrhythmias, Cardiac - complications | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Hemorrhage - chemically induced | Infusions, Intravenous
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force
by Doherty, John U and Gluckman, Ty J and Hucker, William J and Januzzi, James L and Ortel, Thomas L and Saxonhouse, Sherry J and Spinler, Sarah A
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2017, Volume 69, Issue 7, pp. 871 - 898
Periprocedural management of anticoagulation is a common clinical conundrum that involves a multidisciplinary team, cuts across many specialties, and varies... 
surgical procedures | atrial fibrillation | direct-acting anticoagulants | anticoagulation | thrombotic risk | bleeding risk | bridging | warfarin | PREDICTING STROKE | CARDIAC & CARDIOVASCULAR SYSTEMS | PERIOPERATIVE MANAGEMENT | TERM ORAL ANTICOAGULANTS | CHADS-VASC SCORE | BRIDGING THERAPY | EUROPEAN-SOCIETY | STROKE RISK STRATIFICATION | ASSOCIATION PRACTICAL GUIDE | FACTOR XA INHIBITOR | REGIONAL-ANESTHESIA | Anticoagulants | Decision making | Physicians | Colleges & universities
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data
by Heneghan, Carl, Dr and Ward, Alison, PhD and Perera, Rafael, DPhil and Bankhead, Clare, DPhil and Fuller, Alice, BSc and Stevens, Richard, PhD and Bradford, Kairen, MA and Tyndel, Sally, PhD and Alonso-Coello, Pablo, PhD and Ansell, Jack, Prof and Beyth, Rebecca, MD and Bernardo, Artur, MD and Christensen, Thomas Decker, DMSc and Cromheecke, Manon, PhD and Edson, Robert G, MA and Fitzmaurice, David, Prof and Gadisseur, Alain PA, PhD and Garcia-Alamino, Josep M, RN and Gardiner, Chris, PhD and Hasenkam, Michael, Prof and Jacobson, Alan, MD and Kaatz, Scott, DO and Kamali, Farhad, Prof and Khan, Tayyaba Irfan, PhD and Knight, Eve, DipHPsych and Körtke, Heinrich, PhD and Levi, Marcel, PhD and Matchar, David Bruce, Prof and Menéndez-Jándula, Bárbara, MD and Rakovac, Ivo, PhD and Schaefer, Christian and Siebenhofer, Andrea, Prof and Souto, Juan Carlos, PhD and Sunderji, Rubina, Prof and Gin, Kenneth, Prof and Shalansky, Karen, Prof and Völler, Heinz, Prof and Wagner, Otto, MSc and Zittermann, Armin, Prof and Self-Monitoring Trialist Collabora and Self-Monitoring Trialist Collaboration
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9813, pp. 322 - 334
Summary Background Uptake of self-testing and self-management of oral anticoagulation has remained inconsistent, despite good evidence of their effectiveness.... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MANAGEMENT PROGRAM | WARFARIN THERAPY | QUALITY | STROKE PREVENTION | OLDER PATIENTS | GUIDELINES | PROTHROMBIN TIME | RANDOMIZED-TRIAL | INR | ATRIAL-FIBRILLATION | International Normalized Ratio | Vitamin K - antagonists & inhibitors | Anticoagulants - administration & dosage | Thromboembolism - prevention & control | Administration, Oral | Humans | Hemorrhage - chemically induced | Anticoagulants - adverse effects | Drug Monitoring | Self Care | Anticoagulants (Medicine) | Research | Drug therapy | Health aspects | Hemorrhage | Dosage and administration | Oral medication | Patient outcomes | Studies | Intervention | Anticoagulants | Mens health | Cardiac arrhythmia | Womens health | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
by Steinberg, Benjamin A and Steinberg, Benjamin A and Peterson, Eric D and Peterson, Eric D and Kim, Sunghee and Kim, Sunghee and Thomas, Laine and Thomas, Laine and Gersh, Bernard J and Gersh, Bernard J and Fonarow, Gregg C and Fonarow, Gregg C and Kowey, Peter R and Kowey, Peter R and Mahaffey, Kenneth W and Mahaffey, Kenneth W and Sherwood, Matthew W and Sherwood, Matthew W and Chang, Paul and Chang, Paul and Piccini, Jonathan P and Piccini, Jonathan P and Ansell, Jack and Ansell, Jack and Outcomes Registry Better Informed and Outcomes Registry for Better Informed Treatment of Atrial Fibrillation Investigators and Patients
Circulation, ISSN 0009-7322, 02/2015, Volume 131, Issue 5, pp. 488 - 494
Background-Temporary interruption of oral anticoagulation for procedures is often required, and some propose using bridging anticoagulation. However, the use... 
Anticoagulants | Atrial Fibrillation | Outcome assessment (health care) | SURGERY | atrial fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | outcome assessment (health care) | TERM ORAL ANTICOAGULANTS | MOLECULAR-WEIGHT HEPARIN | anticoagulants | PERIPHERAL VASCULAR DISEASE | Prospective Studies | Anticoagulants - administration & dosage | Drug Administration Schedule | Follow-Up Studies | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Humans | Male | Treatment Outcome | Anticoagulants - adverse effects | Hemorrhage - diagnosis | Atrial Fibrillation - epidemiology | Aged, 80 and over | Female | Registries | Aged | Hemorrhage - chemically induced | Atrial Fibrillation - diagnosis | Cohort Studies | Care and treatment | Atrial fibrillation | Outcome and process assessment (Health Care) | Anticoagulants (Medicine) | Research | Health aspects | Hemorrhage | Risk factors | 184 | Original | 174
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure: Substudy of the RE-LY trial
by Douketis, James D and Healey, Jeff S and Brueckmann, Martina and Eikelboom, John W and Ezekowitz, Michael D and Fraessdorf, Mandy and Noack, Herbert and Oldgren, Jonas and Reilly, Paul and Spyropoulos, Alex C and Wallentin, Lars and Connolly, Stuart J and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Uppsala universitet and Institutionen för medicinska vetenskaper
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 3, pp. 625 - 632
In patients with atrial fibrillation (AF) who require interruption of dabigatran or warfarin for an elective surgery/procedure, the risks and benefits of... 
Warfarin | Dabigatran | Bridging anticoagulation | Surgery | PREDICTING STROKE | MANAGEMENT | ORAL ANTICOAGULATION | RISK | CLASSIFICATION | OPEN-LABEL | I TREAT | warfarin | ATRIAL-FIBRILLATION | THERAPY | ETEXILATE | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | surgery | Perioperative Care | Multivariate Analysis | Dabigatran - adverse effects | Dabigatran - administration & dosage | Anticoagulants - administration & dosage | Postoperative Hemorrhage - prevention & control | Humans | Middle Aged | Warfarin - adverse effects | Male | Warfarin - administration & dosage | Time Factors | Adult | Female | Retrospective Studies | Atrial Fibrillation - diagnosis | Odds Ratio | Surgical Procedures, Operative - adverse effects | Blood Loss, Surgical - prevention & control | Stroke - prevention & control | Drug Administration Schedule | Risk Assessment | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | Proportional Hazards Models | Logistic Models | Treatment Outcome | Anticoagulants - adverse effects | Randomized Controlled Trials as Topic | Postoperative Hemorrhage - etiology | Propensity Score | Stroke - etiology | Aged | Elective Surgical Procedures | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)
by Rose, A.J and Hylek, E.M and Ozonoff, A and Ash, A.S and Reisman, J.I and Berlowitz, D.R
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 10/2010, Volume 8, Issue 10, pp. 2182 - 2191
Background: In patients receiving oral anticoagulation, improved control can reduce adverse outcomes such as stroke and major hemorrhage. However, little is... 
Anticoagulants | Warfarin | Chronic disease | Quality of health care | Ambulatory care | CLINICAL-PREDICTION RULES | quality of health care | METAANALYSIS | METHODOLOGICAL STANDARDS | ambulatory care | warfarin | ATRIAL-FIBRILLATION | STROKE | THERAPY | DABIGATRAN | VENOUS THROMBOEMBOLISM | chronic disease | anticoagulants | PERIPHERAL VASCULAR DISEASE | OUTCOMES | HEMATOLOGY | Anticoagulants - administration & dosage | Administration, Oral | Atrial Fibrillation - drug therapy | United States | Veterans | Humans | Middle Aged | Anticoagulants - therapeutic use | Male | Warfarin - therapeutic use | International Normalized Ratio | Regression Analysis | Adult | Female | United States Department of Veterans Affairs | Aged | Cardiology - methods | Health care reform | Chronic diseases | Strategic planning (Business) | Bipolar disorder | Anticoagulants (Medicine) | Public health | Biometry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation (From the ENSURE-AF Trial)
by Lip, Gregory Y H, MD and Al-Saady, Naab, MD, PhD and Jin, James, PhD and Sun, Ming, MS and Melino, Michael, MS, PhD and Winters, Shannon M, MS and Zamoryakhin, Dmitry, MD and Goette, Andreas, MD
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 120, Issue 5, pp. 792 - 796
Abstract In the ENSURE-AF study (NCT 02072434), edoxaban was compared to enoxaparin–warfarin in 2199 patients undergoing electrical cardioversion of... 
Cardiovascular | STROKE | THERAPEUTIC RANGE | CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULANT | QUALITY ANTICOAGULATION | PREDICT | RISK | SAME-TT2R2 SCORE | TIME | OUTCOMES | SPORTIF TRIALS | Single-Blind Method | Stroke - prevention & control | Prospective Studies | Pyridines - administration & dosage | Anticoagulants - administration & dosage | Follow-Up Studies | Atrial Fibrillation - therapy | Humans | Middle Aged | Atrial Fibrillation - complications | Electric Countershock | Male | Thiazoles - administration & dosage | Treatment Outcome | Warfarin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Enoxaparin - administration & dosage | Stroke - etiology | Female | Drug Therapy, Combination | Stroke (Disease) | Hypertension | Care and treatment | Analysis | Atrial fibrillation | Anticoagulants (Medicine) | Electric countershock | Smoking | Myocardial infarction | Heart | Drugs | Cardiac arrhythmia | Transient ischemic attack | Renal function | Liver | Medical services | Alcohol | Congestive heart failure | Bleeding | Confidence intervals | Ratios | Randomization | Fibrillation | Ischemia | Stratigraphy | Thromboembolism | Drug dosages | Age | Vitamin K | Creatinine | Anticoagulants | Cerebral infarction | Stroke | Warfarin | Kidneys | Diabetes mellitus | Regression analysis | Patients | Tobacco | Infarction | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Guidelines on oral anticoagulation with warfarin – fourth edition
by Keeling, David and Baglin, Trevor and Tait, Campbell and Watson, Henry and Perry, David and Baglin, Caroline and Kitchen, Steve and Makris, Michael and British Comm Stand Haematology and British Committee for Standards in Haematology
British Journal of Haematology, ISSN 0007-1048, 08/2011, Volume 154, Issue 3, pp. 311 - 324
vitamin K antagonist | anticoagulation | warfarin | Vitamin K antagonist | Warfarin | Anticoagulation | VITAMIN-K SUPPLEMENTATION | LONG-TERM ANTICOAGULATION | FATAL PULMONARY-EMBOLISM | DEEP-VEIN THROMBOSIS | ANTIPLATELET THERAPY | LOW-INTENSITY | ATRIAL-FIBRILLATION | RECURRENT VENOUS THROMBOEMBOLISM | ANTITHROMBOTIC THERAPY | INTERNATIONAL NORMALIZED RATIO | HEMATOLOGY | Pulmonary Embolism - prevention & control | Anticoagulants - administration & dosage | Drug Administration Schedule | Administration, Oral | Hemorrhage - therapy | Humans | Warfarin - adverse effects | Anticoagulants - therapeutic use | Drug Monitoring - methods | Anticoagulants - adverse effects | Warfarin - administration & dosage | Warfarin - therapeutic use | International Normalized Ratio | Drug Interactions | Perioperative Care - methods | Venous Thrombosis - prevention & control | Craniocerebral Trauma - complications | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Guidelines on oral anticoagulation (warfarin): third edition – 2005 update
by Baglin, T. P and Keeling, D. M and Watson, H. G and British Comm Standards Haematology and British Committee for Standards in Haematology
British Journal of Haematology, ISSN 0007-1048, 02/2006, Volume 132, Issue 3, pp. 277 - 285
vitamin K antagonists | oral anticoagulation | guideline | warfarin | Guideline | Oral anticoagulation | Warfarin | Vitamin K antagonists | LONG-TERM | 1ST EPISODE | PERIOPERATIVE MANAGEMENT | MYOCARDIAL-INFARCTION | INDUCTION REGIMEN | LOW-INTENSITY | ATRIAL-FIBRILLATION | RECURRENT VENOUS THROMBOEMBOLISM | MOLECULAR-WEIGHT HEPARIN | ANTITHROMBOTIC THERAPY | HEMATOLOGY | Anticoagulants - administration & dosage | Administration, Oral | Heart Valve Prosthesis | Humans | Medical Audit - methods | Heparin, Low-Molecular-Weight - therapeutic use | Warfarin - administration & dosage | Neoplasms - drug therapy | Hemoglobinuria - drug therapy | Vitamin K - antagonists & inhibitors | Self Administration - methods | Perioperative Care - methods | Thromboembolism - drug therapy | Thrombosis - drug therapy | Thrombophilia - drug therapy | Electric Countershock - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Bridging Anticoagulation Primum Non Nocere
by Rechenmacher, Stephen J and Fang, James C
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2015, Volume 66, Issue 12, pp. 1392 - 1403
Chronic oral anticoagulation frequently requires interruption for various reasons and durations. Whether or not to bridge with heparin or other anticoagulants... 
perioperative | Key Words bleeding | periprocedural | thromboembolism | bridging | CARDIAC & CARDIOVASCULAR SYSTEMS | bleeding | ACUTE CATHETERIZATION | RANDOMIZED EVALUATION | PERCUTANEOUS CORONARY INTERVENTION | VENOUS THROMBOEMBOLISM | WARFARIN INTERRUPTION | NONCARDIAC SURGERY | ORAL ANTICOAGULANTS | DEFIBRILLATOR SURGERY | NONVALVULAR ATRIAL-FIBRILLATION | PERIOPERATIVE ANTICOAGULATION | Perioperative Care | Anticoagulants - administration & dosage | Thromboembolism - prevention & control | Humans | Observational Studies as Topic | Hemorrhage - chemically induced | Anticoagulants - adverse effects | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights